• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue3

Assessment of Response to Anti Leukotriene Among Children with Bronchial Asthma

    Naser Miftah Asmaydeh Al Shehibi Khalid Mohamed Salah,Mohamed Mohamed Abdel Salam, Rania Mohamed Mohamed Ibrahim

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 3000-3008

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background:Asthma is a chronic inflammatory disease of airways in which many cells and
cellular elements play a role in particular, mast cells, eosinophils, T lymphocytes, macrophages,
neutrophils and epithelial cells. Inflammation causes recurrent series of wheezing,
breathlessness, chest tightness and coughing, particularly at night or in the early morning.
These episodes are usually associated with widespread and variable airflow obstruction that is
often reversible either spontaneously or with treatment.The inflammatory process can lead to an
associated increase in bronchial hyper- responsiveness (BHR) to a variety of stimuli (e.g.,
allergens, respiratory viruses and some occupational exposures). Reversibility of airflow
limitation may be incomplete in some asthmatic patients.Asthma is a heterogeneous disorder,
with different mechanism of disease processes. Many clusters of demographics, clinical and
pathophysiological characteristics are often called "asthma phenotypes"The
antibronchoconstrictor efficacy of antileukotriene drugs provided the main impetus behind their
introduction as the first novel class of asthma therapy in more than 20 yr. However, clinical
trials also provided surprising evidence for a hitherto unsuspected role of cysteinyl-leukotrienes
in promoting persistent eosinophilia in the airway and blood of patients with asthma, and
possibly influencing pathways involved in airway wall remodeling. A better under
Keywords:
    Bronchial Asthma (BA) Anti Leukotriene
  • PDF (469 K)
  • XML
(2021). Assessment of Response to Anti Leukotriene Among Children with Bronchial Asthma. European Journal of Molecular & Clinical Medicine, 8(3), 3000-3008.
Naser Miftah Asmaydeh Al Shehibi; Khalid Mohamed Salah,Mohamed Mohamed Abdel Salam, Rania Mohamed Mohamed Ibrahim. "Assessment of Response to Anti Leukotriene Among Children with Bronchial Asthma". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 3000-3008.
(2021). 'Assessment of Response to Anti Leukotriene Among Children with Bronchial Asthma', European Journal of Molecular & Clinical Medicine, 8(3), pp. 3000-3008.
Assessment of Response to Anti Leukotriene Among Children with Bronchial Asthma. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 3000-3008.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 138
  • PDF Download: 236
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus